no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A best fit regression analysis to predict dosimetric parameters in prostate brachytherapy using 131Cs given the impact of changing prostate edema
|
Kehwar, Than S. |
|
2009 |
8 |
2 |
p. 166 |
article |
2 |
Accelerated partial breast irradiation for Asian women with Stage 0 or I breast cancer – A Phase II toxicity study
|
Tang, Johann I. |
|
2009 |
8 |
2 |
p. 140 |
article |
3 |
Accelerated partial breast irradiation using balloon brachytherapy for ductal carcinoma in situ of the breast: A 5-year experience
|
Prestidge, Bradley R. |
|
2009 |
8 |
2 |
p. 107 |
article |
4 |
A comparative clinical study and dosimetry planning experience with the new Contura™ multi-lumen versus MammoSite® single-lumen high-dose-rate balloon breast applicators under the RTOG 0413 protocol
|
Morcovescu, Serban |
|
2009 |
8 |
2 |
p. 136-137 |
article |
5 |
A Comparison Between LDR and MRI Conformal HDR Brachytherapy of Cervical Cancer: Results, Patterns of Failure and Late Complications
|
Bernshaw, David L. |
|
2009 |
8 |
2 |
p. 111 |
article |
6 |
A comparison of post-implant US/CT image fusion and MRI/CT image fusion for 125I prostate brachytherapy post implant dosimetry
|
Patanjali, Nitya |
|
2009 |
8 |
2 |
p. 124 |
article |
7 |
A comparison of skin and chest wall dose delivered with multicatheter, Contura™ Multilumen Balloon, and MammoSite® breast brachytherapy
|
Cuttino, Laurie W. |
|
2009 |
8 |
2 |
p. 118 |
article |
8 |
A comparison of the biological effective dose of 50 KV electronic brachytherapy to 192Ir high-dose-rate brachytherapy for vaginal cuff irradiation
|
Markelewicz, Robert J. |
|
2009 |
8 |
2 |
p. 126-127 |
article |
9 |
A comparison study of technique, limitations and clinical outcome of MammoSite® vs. SAVI for partial breast brachytherapy
|
Youssef, Ashraf |
|
2009 |
8 |
2 |
p. 139 |
article |
10 |
A correlation of bladder and rectal point doses with 3-d volume-based treatment planning for intracavitary brachytherapy in the treatment of locally advanced cervical cancers
|
Chatterjee, Koushik |
|
2009 |
8 |
2 |
p. 143-144 |
article |
11 |
Adjuvant high-dose-rate brachytherapy in adults with soft tissue sarcoma: A single institution experience
|
Shultz, David B. |
|
2009 |
8 |
2 |
p. 134 |
article |
12 |
A dosimetric comparison of AccuBoost® noninvasive partial breast brachytherapy to electron beam tumor bed boost and 3-D conformal accelerated partial breast irradiation
|
Sioshansi, Shirin |
|
2009 |
8 |
2 |
p. 117 |
article |
13 |
A dosimetric comparison of the model 6711 125I source and a new, smaller diameter brachytherapy seed (model 9011) using Monte Carlo methods
|
Rivard, Mark J. |
|
2009 |
8 |
2 |
p. 114 |
article |
14 |
American Brachytherapy Society 2009 Annual Meeting Program
|
|
|
2009 |
8 |
2 |
p. 85-93 |
article |
15 |
An evaluation of implant needle motion with high-dose-rate brachtherapy for prostate cancer
|
Agustin, Jeffrey |
|
2009 |
8 |
2 |
p. 167-168 |
article |
16 |
An investigation of effective optimization algorithm for ultrasound based real time high-dose-rate brachytherapy for the prostate
|
Pokharel, Shyam |
|
2009 |
8 |
2 |
p. 155-156 |
article |
17 |
A novel approach to manage gastric adenocarcinoma
|
Hariri, Sanaz |
|
2009 |
8 |
2 |
p. 158-159 |
article |
18 |
A novel brachytherapy source and delivery system for use in conjunction with VATS wedge resection of early-stage lung cancer
|
Wazer, David E. |
|
2009 |
8 |
2 |
p. 133-134 |
article |
19 |
A preliminary quality of life assessment of genitourinary and gastrointestinal toxicity comparing two fractions versus four fractions high dose radiation alone in early prostate cancer patients
|
McPhee, Kathleen A. |
|
2009 |
8 |
2 |
p. 119 |
article |
20 |
A prospective randomized study to compare the short-term urinary function between silodosin and tamsulosin after 125I prostate brachytherapy
|
Ikeda, Tetsuhiro |
|
2009 |
8 |
2 |
p. 170 |
article |
21 |
A report on the initial experience with the Mick CT-compatible high-dose-rate split ring applicator®
|
Juliano, Justin J. |
|
2009 |
8 |
2 |
p. 129 |
article |
22 |
A retrospective comparison of vaginal brachytherapy alone vs. brachytherapy and external beam therapy as adjuvant treatment for intermediate-risk endometrial cancer
|
Feldmeier, John J. |
|
2009 |
8 |
2 |
p. 143 |
article |
23 |
A semi-automatic segmentation method for prostate boundary delineation
|
Mahdavi, Seyedeh Sara |
|
2009 |
8 |
2 |
p. 175 |
article |
24 |
Association between erectile function and lower urinary tract symptoms in patients treated with permanent seed prostate brachytherapy
|
Taussky, Daniel |
|
2009 |
8 |
2 |
p. 170-171 |
article |
25 |
Author Index, 30th Annual Meeting of the American Brachytherapy Society
|
|
|
2009 |
8 |
2 |
p. 265-267 |
article |
26 |
Automated 2D/3D registration algorithm for high-dose-rate lung brachytherapy
|
Zvonarev, Pavel S. |
|
2009 |
8 |
2 |
p. 129-130 |
article |
27 |
Bilateral perineural invasion on prostate biopsy significantly lowers five year cancer free survival in patients treated with prostate brachytherapy
|
Shanahan, Thomas G. |
|
2009 |
8 |
2 |
p. 178 |
article |
28 |
Brachytherapy dosimetry simulation of eye physics slotted plaque: A Monte Carlo study
|
Owrangi, Amir M. |
|
2009 |
8 |
2 |
p. 131 |
article |
29 |
Brachytherapy treatment planning for complex applicators based on the AAPM TG-43 dosimetry algorithm: Case studies and clinical impact
|
Rivard, Mark J. |
|
2009 |
8 |
2 |
p. 106 |
article |
30 |
Classification of rectal complications using the Expanded Prostate Cancer Index Composite: Correlation with dose depends on interpretation of the scores
|
Tack, Krystina M. |
|
2009 |
8 |
2 |
p. 164-165 |
article |
31 |
Clinical and dosimetric variables associated with acute bowel toxicity following prostate seed brachytherapy with 131Cs
|
Gokhale, Abhay S. |
|
2009 |
8 |
2 |
p. 170 |
article |
32 |
Clinical experience with GAF chromic film for dose measurements in high-dose-rate brachytherapy surface applicator (Leipzig) treatments: Phantom and patient results
|
Gary Kuo, Hsiang-Chi |
|
2009 |
8 |
2 |
p. 153 |
article |
33 |
Clinical feasibility of multiple outpatient high-dose-rate brachytherapy insertions through a cervical sleeve and three-dimensional dosimetry for inoperable endometrial cancer
|
Mehta, Keyur |
|
2009 |
8 |
2 |
p. 141 |
article |
34 |
Clinical impact of dose volume adaptation and dose escalation in MRI-guided high-dose-rate brachytherapy including the use of combined intracavitary/interstitial techniques for patients with poor response cervical cancer FIGO stage IIB or IIIB
|
Sturdza, Alina E. |
|
2009 |
8 |
2 |
p. 113 |
article |
35 |
C4 MRI ECAMS have no effect on 125I seed anisotropy and are visibile after radiaton exposure
|
Frank, Steven J. |
|
2009 |
8 |
2 |
p. 172 |
article |
36 |
Comparative study of permanent interstitial prostate brachytherapy post-implant evaluation among two North American institutes
|
Balbontin, Felipe G. |
|
2009 |
8 |
2 |
p. 179 |
article |
37 |
Comparison of CT and MRI cervical cancer brachytherapy target and normal tissue volumes
|
Eskander, Ramez N. |
|
2009 |
8 |
2 |
p. 111-112 |
article |
38 |
Comparison of CT vs. ultrasound to determine prostate volume prior to real-time ultrasound based intraoperative planning for 125I seed implantation
|
Fogh, Shannon E. |
|
2009 |
8 |
2 |
p. 176 |
article |
39 |
Comparison of heart dose of external beam therapy and multi-channel high-dose-rate breast applicators
|
Axelrod, Steve |
|
2009 |
8 |
2 |
p. 152 |
article |
40 |
Comparison of outcomes of lung cancer patients treated with surgical resection with 125I lung brachytherapy vs stereotactic hypofractionated radiation therapy for single lung lesions
|
Parashar, Bhupesh |
|
2009 |
8 |
2 |
p. 159-160 |
article |
41 |
Comparison of tumor control outcomes and toxicity between LDR brachytherapy and high dose IMRT for clinically localized prostate cancer
|
Zelefsky, Michael J. |
|
2009 |
8 |
2 |
p. 105 |
article |
42 |
Cone beam computed tomography as a way to assess and reduce the dosimetric impact of interfraction catheter displacement in prostate high-dose-ratebrachytherapy
|
Foster, William |
|
2009 |
8 |
2 |
p. 167 |
article |
43 |
Contura™ multi-lumen radiation balloon brachytherapy applicator: A potential advantage for patients with early breast cancer
|
Ghaly, Maged |
|
2009 |
8 |
2 |
p. 137 |
article |
44 |
Correlation between low dose hyper-radiosensitivity and low-dose-rate hyperradiosensitivity from the “inverse” dose rate effect – Potential influence in low-dose-rate brachytherapy
|
Leonard, Bobby E. |
|
2009 |
8 |
2 |
p. 156 |
article |
45 |
Counterpoint: Conformal external beam for accelerated partial breast irradiation
|
Taghian, Alphonse G. |
|
2009 |
8 |
2 |
p. 184-188 |
article |
46 |
CT simulation as a pretreatment quality assurance tool for elliptical MammoSite® balloons
|
Doyle, Laura |
|
2009 |
8 |
2 |
p. 135-136 |
article |
47 |
Curvilinear brachytherapy source characterization in a conventional treatment planning system using the AAPM TG-43 polar coordinate system
|
Bannon, Elizabeth A. |
|
2009 |
8 |
2 |
p. 147 |
article |
48 |
Definitive radiation therapy for endometrial cancer in medically-inoperable elderly patients
|
Wegner, Rodney E. |
|
2009 |
8 |
2 |
p. 142-143 |
article |
49 |
Description and predictive factors of urinary toxicity following prostate brachytherapy using 131Cs
|
Smith, Ryan P. |
|
2009 |
8 |
2 |
p. 172-173 |
article |
50 |
Determination of the dosimetric characteristics of a new polymer-encapsulated, elongated, 103Pd brachytherapy source using Monte Carlo calculations
|
Paxton, Adam B. |
|
2009 |
8 |
2 |
p. 149-150 |
article |
51 |
Development of super miniature x-ray tube for brachytherapy using carbon nanotube field emitters
|
Heo, Sunghwan |
|
2009 |
8 |
2 |
p. 149 |
article |
52 |
Does equivalent uniform dose affect toxicity for high-dose-rate brachytherapy using the MammoSite® applicator?
|
Stewart, Alexandra J. |
|
2009 |
8 |
2 |
p. 138 |
article |
53 |
Does treatment time or source strength affect late toxicity in accelerate partial breast irradiation brachytherapy?
|
Heffernan, Jill |
|
2009 |
8 |
2 |
p. 118-119 |
article |
54 |
Dose calculations around elongated curved brachytherapy sources
|
Aryal, Prakash |
|
2009 |
8 |
2 |
p. 148 |
article |
55 |
Dose escalation to the dominant intraprostatic lesion defined by sextant biopsy in a permanent prostate 125I implant: A prospective comparative dosimetric and toxicity analysis
|
Gaudet, Marc |
|
2009 |
8 |
2 |
p. 177-178 |
article |
56 |
Dose escalation with high-dose 3D-conformal radiotherapy (HD-3D-CRT) or low-dose 3D-conformal radiotherapy plus HDR brachytherapy (LD-3D-CRT+HDR-B) for intermediate- or high-risk prostate cancer: Early results of a prospective comparative trial
|
Guix, Benjamin |
|
2009 |
8 |
2 |
p. 105-106 |
article |
57 |
Dosimetric analysis of biochemical outcome following 125I permanent prostate brachytherapy
|
Stephans, Kevin L. |
|
2009 |
8 |
2 |
p. 169 |
article |
58 |
Dosimetric analysis of 3D image-guided high-dose-rate brachytherapy planning for the treatment of cervical cancer
|
Kim, Hayeon |
|
2009 |
8 |
2 |
p. 127 |
article |
59 |
Dosimetric characteristics of a 32P film source for surface irradiation
|
Munro III, John J. |
|
2009 |
8 |
2 |
p. 151 |
article |
60 |
Dosimetric characterization of the thermobrachytherapy surface applicator
|
Craciunescu, Oana I. |
|
2009 |
8 |
2 |
p. 157-158 |
article |
61 |
Dosimetric effect of interfractional catheter displacement in prostate high-dose-rate brachytherapy
|
Kovalchuk, Nataliya |
|
2009 |
8 |
2 |
p. 114-115 |
article |
62 |
Dosimetric evaluation of internal shielding in a high-dose-rate skin applicator
|
Lliso, Francoise |
|
2009 |
8 |
2 |
p. 150-151 |
article |
63 |
Dosimetric investigation of a 90Sr/90Y source for intra-ocular treatment of age-related wet macular degeneration
|
Holmes, Shannon M. |
|
2009 |
8 |
2 |
p. 132 |
article |
64 |
Dosimetric measurements of a new electronic brachytherapy surface applicator
|
Axelrod, Steve |
|
2009 |
8 |
2 |
p. 151-152 |
article |
65 |
Dosimetric study of permanent prostate brachytherapy utilizing 131Cs, 125I and 103Pd seeds
|
Yang, Ruijie |
|
2009 |
8 |
2 |
p. 156 |
article |
66 |
Early mortality after treatment for localized prostate cancer
|
Reddy, Chandana A. |
|
2009 |
8 |
2 |
p. 160 |
article |
67 |
Editorial Board
|
|
|
2009 |
8 |
2 |
p. A1 |
article |
68 |
Effect of prostate-specific antigen bounce on outcome in patients treated with permanent 125I-seed prostate brachytherapy
|
Zwahlen, Daniel R. |
|
2009 |
8 |
2 |
p. 161 |
article |
69 |
Effects of 3-month neoadjuvant hormonal therapy before permanent seed implant brachytherapy on disease-specific and global health related quality of life, urinary complaints and prostate-specific antigen course
|
Davits, Rob |
|
2009 |
8 |
2 |
p. 163-164 |
article |
70 |
Erectile function durability following permanent prostate brachytherapy
|
Taira, Al V. |
|
2009 |
8 |
2 |
p. 168 |
article |
71 |
Evaluation of different inverse planning algorithms for high-dose-rate prostate brachytherapy
|
Sangalli, Giulia |
|
2009 |
8 |
2 |
p. 148-149 |
article |
72 |
Evaluation of long-term bowel and urinary toxicity after permanent prostate brachytherapy
|
Stephans, Kevin L. |
|
2009 |
8 |
2 |
p. 120 |
article |
73 |
Evaluation of methods of interpolation-extrapolation of gL(r) and F(r,θ) for high-energy brachytherapy sources
|
Pujades-Claumarchirant, M. Carmen |
|
2009 |
8 |
2 |
p. 131-132 |
article |
74 |
Evidence of a urinary flare and a prostate-specific antigen bounce in a multi-institutional 131Cs monotherapy trial
|
Prestidge, Bradley R. |
|
2009 |
8 |
2 |
p. 174 |
article |
75 |
Experimental determination of the dose perturbation to clinically defined bladder and rectal points for a shielded intracavitary tandem & ovoid applicator in high-dose-rate brachytherapy
|
Stanley, Thomas R. |
|
2009 |
8 |
2 |
p. 122-123 |
article |
76 |
Factors impacting all cause mortality in men receiving androgen deprivation therapy with prostate brachytherapy
|
Taira, Al V. |
|
2009 |
8 |
2 |
p. 165-166 |
article |
77 |
Factors predicting prostate gland shrinkage following neoadjuvant cytoreductive therapy
|
Merrick, Gregory S. |
|
2009 |
8 |
2 |
p. 165 |
article |
78 |
Feasibility and early outcomes (toxicities, cosmesis) of accelerated partial breast irradiation with MammoSite® balloon delivery system in patients with early stage breast cancer
|
Desai, Gopal R. |
|
2009 |
8 |
2 |
p. 140-141 |
article |
79 |
Feasibility of marker-catheters for a titanium tandem and ovoids applicator in MRI-guided bracytherapy: Implications on applicator reconstruction on 3 Tesla MRI
|
Kim, Yusung |
|
2009 |
8 |
2 |
p. 121 |
article |
80 |
Five-year results of accelerated partial breast irradiation for ductal carcinoma in situ treated by interstitial multicatheter high-dose-rate brachytherapy or MammoSite®
|
Adkison, Jarrod B. |
|
2009 |
8 |
2 |
p. 107-108 |
article |
81 |
Guide for Authors
|
|
|
2009 |
8 |
2 |
p. A7 |
article |
82 |
145 Gy vs. 160 Gy for a prescription dose: A comparison of dosimetry and acute toxicity in 125I permanent implant for prostate cancer
|
Yorozu, Atsunori |
|
2009 |
8 |
2 |
p. 160-161 |
article |
83 |
High-dose-rate brachyhterapy as a boost for carcinoma of the oral tongue
|
Akl, Ahmed M. |
|
2009 |
8 |
2 |
p. 159 |
article |
84 |
High-dose-rate brachytherapy as monotherapy delivered in two fractions over one day for favorable-risk prostate cancer. Preliminary toxicity data
|
Ghilezan, Michel |
|
2009 |
8 |
2 |
p. 176 |
article |
85 |
High-dose-rate brachytherapy for cervix carcinoma using the Nice gynecologic applicator: A new procedure combining endocavitary and interstitial approach
|
Hannoun-Levi, Jean-Michel |
|
2009 |
8 |
2 |
p. 128-129 |
article |
86 |
High-dose-rate brachytherapy source tracking by MOSFET dosimetry system
|
Ivanova, Tatjana |
|
2009 |
8 |
2 |
p. 130 |
article |
87 |
High-dose-rate interstitial brachytherapy for previously untreated cervical carcinoma
|
Isohashi, Fumiaki |
|
2009 |
8 |
2 |
p. 234-239 |
article |
88 |
High-dose-rate intracavitary brachytherapy in locally advanced uterine cervix cancer using three different fractionation schedules: An Indian experience
|
Kundu, Sayan |
|
2009 |
8 |
2 |
p. 111 |
article |
89 |
High-dose-rate prostate brachytherapy and supplemental external beam radiotherapy: A comparison of single fraction 15Gy high-dose-rate and hypofractionated external beam to a conventional fractionated regimen
|
Morton, Gerard C. |
|
2009 |
8 |
2 |
p. 110 |
article |
90 |
High-dose-rate salvage treatment of prostate-specifc antigen only recurrent prostate cancer after radical prostatectomy: A feasibility study in 5 patients
|
Mark, Rufus J. |
|
2009 |
8 |
2 |
p. 164 |
article |
91 |
Higher rate of prostate-specific antigen bounce ≥2 ng/mL with brachytherapy in young prostate cancer patients
|
Park, Sean |
|
2009 |
8 |
2 |
p. 172 |
article |
92 |
1H-MR spectroscopic imaging of prostate pre- and post-brachytherapy: Present and future
|
Damyanovich, Andrei |
|
2009 |
8 |
2 |
p. 166-167 |
article |
93 |
Hormonal blockade for salvage treatment of prostate-specific antigen only recurrent prostate cancer after interstitial high-dose-rate brachytherapy for early stage prostate cancer: long-term followup in 23 patients
|
Mark, Rufus J. |
|
2009 |
8 |
2 |
p. 164 |
article |
94 |
125I brachytherapy as monotherapy in patients aged ≤55 years with localized prostate cancer
|
Gomez-Iturriaga, Alfonso |
|
2009 |
8 |
2 |
p. 120 |
article |
95 |
Image fusion of prostate preplan transrectal ultrasound and post 125I-seed implant ct images to improve consistency and accuracy of post-seed implant quality statistics
|
Smith, Ryan L. |
|
2009 |
8 |
2 |
p. 116 |
article |
96 |
Image-guided intracavitary high-dose-rate brachytherapy for cervix cancer: A single institutional experience with three-dimensional CT-based planning
|
Wang, Brian |
|
2009 |
8 |
2 |
p. 240-247 |
article |
97 |
Imaging technologies for cervical cancer brachytherapy: a systematic review
|
D'Souza, David P. |
|
2009 |
8 |
2 |
p. 143 |
article |
98 |
Impact of age on biochemical control in a cohort of intermediate- and high-risk prostate cancer patients treated with high-dose-rate brachytherapy boost combined with pelvic external beam radiation therapy
|
Limbacher, Amy L. |
|
2009 |
8 |
2 |
p. 174 |
article |
99 |
Impact of transrectal ultrasound- and computed tomography-based seed localization on postimplant dosimetry in prostate brachytherapy
|
Chew, Meng-Sang |
|
2009 |
8 |
2 |
p. 255-264 |
article |
100 |
Influence of isotope selection on morbidity of external beam radiotherapy with low-dose-rate boost for prostate cancer
|
Chino, Junzo P. |
|
2009 |
8 |
2 |
p. 175-176 |
article |
101 |
Initial clinical experience with a single entry multichannel brachytherapy device, SAVI, for accelerated partial breast irradiation
|
Yashar, Catheryn M. |
|
2009 |
8 |
2 |
p. 116-117 |
article |
102 |
Initial dosimetric experience: Contura™ Multilumen Balloon Registry Trial
|
Arthur, Douglas W. |
|
2009 |
8 |
2 |
p. 117-118 |
article |
103 |
Initial radiation experience evaluating early tolerance and toxicities in patients undergoing accelerated partial breast irradiation using the Contura Multi-Lumen Balloon breast brachytherapy catheter
|
Brown, Sheree |
|
2009 |
8 |
2 |
p. 227-233 |
article |
104 |
Inoperable endometrial carcinoma treated with definitive radiotherapy: Survival, local control, and treatment side effects
|
Duncan, Casey |
|
2009 |
8 |
2 |
p. 141 |
article |
105 |
Interface dosimetry for electronic brachytherapy Xoft balloon applicators
|
Segala, James |
|
2009 |
8 |
2 |
p. 123-124 |
article |
106 |
Interobserver study of countouringbased on ultrasound image in real-time interactive prostate brachytherapy
|
Rodriguez, Silvia |
|
2009 |
8 |
2 |
p. 173-174 |
article |
107 |
Interstitial brachytherapy as boost for T4 locally advanced head and neck cancer
|
Do, Ly V. |
|
2009 |
8 |
2 |
p. 133 |
article |
108 |
Interstitial high-dose-rate brachytherapy for breast cancer in women ≤50 years of age compared to >50 years of age. A report of 192 cases using multicatheter technique
|
Mark, Rufus J. |
|
2009 |
8 |
2 |
p. 139 |
article |
109 |
Interstitial high-dose-rate brachytherapy for ductal carcinoma in situ of the breast: Median 5-year followup of 44 cases using multicatheter technique
|
Mark, Rufus J. |
|
2009 |
8 |
2 |
p. 137-138 |
article |
110 |
Interstitial high-dose-rate brachytherapy for early stage breast cancer: Median 5-year followup of 192 cases using multicatheter technique
|
Mark, Rufus J. |
|
2009 |
8 |
2 |
p. 108-109 |
article |
111 |
Interstitial high-dose-rate brachytherapy + intensity modulated radiation therapy vs. high-dose-rate monotherapy for early stage prostate cancer: Median 7-year followup in 380 cases
|
Mark, Rufus J. |
|
2009 |
8 |
2 |
p. 109 |
article |
112 |
Inverse-planned image-guided robotic brachytherapy: Preclinical proofs of principle
|
Cunha, J. Adam M. |
|
2009 |
8 |
2 |
p. 115-116 |
article |
113 |
In vivo dose measurements for high-dose-rate brachytherapy using a new scintillating fiber dosimetry system: A prostate phantom study
|
Therriault-Proulx, Francois |
|
2009 |
8 |
2 |
p. 115 |
article |
114 |
Iris melanoma brachytherapy treatment using modified COMS plaque
|
Kovalchuk, Nataliya |
|
2009 |
8 |
2 |
p. 150 |
article |
115 |
Japanese clinical outcome in patients with locally and locally advanced prostate cancer treated with high-dose-rate brachytherapy
|
Jo, Yoshimasa |
|
2009 |
8 |
2 |
p. 169-170 |
article |
116 |
Listing of Plenary, Oral and Poster Presentations of the 30th Annual Meeting of the American Brachytherapy Society
|
|
|
2009 |
8 |
2 |
p. 94-104 |
article |
117 |
Loading pattern calculated by inverse optimization vs traditional dosimetry systems of intracavitary brachytherapy of cervical cancer – A dosimetric study
|
Swamidas, Jamema V. |
|
2009 |
8 |
2 |
p. 127-128 |
article |
118 |
Logistics of tandem and ovoids HDR plan optimization in MRI-guided brachytherapy for cervical cancer: Comparisons of standard, graphical, and inverse optimizations
|
Kim, Yusung |
|
2009 |
8 |
2 |
p. 121-122 |
article |
119 |
Long-term outcome of MRSI-directed dose escalation for prostate brachytherapy
|
Yuen, Jasper |
|
2009 |
8 |
2 |
p. 168 |
article |
120 |
Long-term results of the German-Austrian phase II study – accelerated partial breast irradiation using multicatheter brachytherapy for early breast cancer
|
Strnad, Vratislav |
|
2009 |
8 |
2 |
p. 107 |
article |
121 |
Masthead
|
|
|
2009 |
8 |
2 |
p. A2 |
article |
122 |
Maximal 3-D dose to the whole bladder versus bladder wall in image-guided high-dose-rate intracavitary brachytherapy planning with bladder distension for cervical cancer
|
Monaghan, M. |
|
2009 |
8 |
2 |
p. 142 |
article |
123 |
Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models
|
Thomson, Rowan M. |
|
2009 |
8 |
2 |
p. 130-131 |
article |
124 |
Monte Carlo inverse planning in high-dose-rate brachytherapy: The impact of source energy spectra on heterogeneities and boundaries
|
D'Amours, Michel |
|
2009 |
8 |
2 |
p. 145-146 |
article |
125 |
Monte Carlo simulations and radiation dosimetry measurements of peripherally-applied high-dose-rate 192Ir breast brachytherapy D-shaped applicators
|
Yang, Yun |
|
2009 |
8 |
2 |
p. 134-135 |
article |
126 |
Morbidity and prostate-specific antigen control of external beam radiation therapy plus low-dose-rate brachytherapy boost for low, intermediate, and high-risk prostate cancer
|
Koontz, Bridget F. |
|
2009 |
8 |
2 |
p. 191-196 |
article |
127 |
MRI-guided high-dose-rate intracavitary brachytherapy in cervical cancers at Tata Memorial Hospital: The initial clinical outcome
|
Mahantshetty, Umesh M. |
|
2009 |
8 |
2 |
p. 112 |
article |
128 |
Multi-image fusions and their role in inverse planned high-dose-rate prostate brachytherapy for dose escalation of dominant intraprostatic lesions defined by combined MRI/MRSI
|
Pouliot, Jean |
|
2009 |
8 |
2 |
p. 113-114 |
article |
129 |
Obesity does not predict Gleason score, tumor location or cancer volume following transperineal template-guided prostate mappy biopsy
|
Allen, Zachariah A. |
|
2009 |
8 |
2 |
p. 173 |
article |
130 |
Oncentra brachy commissioning
|
Frigerio, Cristina |
|
2009 |
8 |
2 |
p. 147-148 |
article |
131 |
One-year results of 125I vs. 131Cs prospective randomized trial on urinary function following prostate brachytherapy
|
Moran, Brian J. |
|
2009 |
8 |
2 |
p. 109-110 |
article |
132 |
On the impacts of the uncertainty of tissue chemical composition on dose distribution for breast low-dose-rate brachytherapy
|
Afsharpour, Hossein |
|
2009 |
8 |
2 |
p. 146 |
article |
133 |
Outcomes in patients with HER2 overexpressing and triple negative phenotypes treated with partial breast irradiation using MammoSite® brachytherapy
|
Sharma, Neha |
|
2009 |
8 |
2 |
p. 139-140 |
article |
134 |
Outcomes of high dose rate interstitial boost brachytherapy after external beam radiation therapy in head and neck cancer—An Indian (single institutional) learning experience
|
Patra, Niladri B. |
|
2009 |
8 |
2 |
p. 248-254 |
article |
135 |
Partial breast irradiation and cardiac dose
|
Benda, Rashmi |
|
2009 |
8 |
2 |
p. 116 |
article |
136 |
Peak flow rate is the best predictor of acute urinary retention following low-dose-rate brachytherapy
|
Ikeda, Tetsuhiro |
|
2009 |
8 |
2 |
p. 162-163 |
article |
137 |
Permanent prostate brachytherapy in prostate glands less than 20 cm3
|
Mayadev, Jyoti |
|
2009 |
8 |
2 |
p. 119-120 |
article |
138 |
Permanent prostate brachytherapy preplanned technique: The modern Seattle method step-by-step and dosimetric outcomes
|
Sylvester, John E. |
|
2009 |
8 |
2 |
p. 197-206 |
article |
139 |
Point: Brachytherapy for accelerated partial breast irradiation
|
Wazer, David E. |
|
2009 |
8 |
2 |
p. 181-183 |
article |
140 |
Post-implant rectal dosimetry is not dependent on 103Pd or 125I seed activity
|
Merrick, Gregory S. |
|
2009 |
8 |
2 |
p. 125 |
article |
141 |
Preoperative endorectal high-dose-rate brachytherapy: Pathologic downstaging in locally advanced rectal cancer
|
Ghaly, Maged |
|
2009 |
8 |
2 |
p. 133 |
article |
142 |
Previous transurethral resection of the prostate is not a contraindication for interstitial high-dose-rate brachytherapy for prostate cancer
|
Mark, Rufus J. |
|
2009 |
8 |
2 |
p. 160 |
article |
143 |
Prospective evaluation of erectile function using International Index of Erectile Function score after 125I permanent prostate brachytherapy
|
Patil, Nikhilesh G. |
|
2009 |
8 |
2 |
p. 171 |
article |
144 |
Prostate brachytherapy biochemical relapse-free survival outcomes in intermediate-risk prostate cancer patients
|
Sylvester, John E. |
|
2009 |
8 |
2 |
p. 176-177 |
article |
145 |
Prostate-specific antigen bounce after external beam radiotherapy plus high-dose-rate brachytherapy boost for definitive management of localized prostate cancer
|
Peddada, Anuj V. |
|
2009 |
8 |
2 |
p. 178-179 |
article |
146 |
PSA kinetics >5 years after treatment with brachytherapy or external beam radiotherapy: Defining the long-term PSA profile for biochemical control
|
Ciezki, Jay P. |
|
2009 |
8 |
2 |
p. 120-121 |
article |
147 |
Pulmonary seed embolization after transperineal interstitial prostate brachytherapy: Does small prostate gland or seed placement outside the prostate capsule increase frequency of seed loss?
|
Yousuf, Junaid |
|
2009 |
8 |
2 |
p. 171-172 |
article |
148 |
Quadrant dosimetry as a predictor of biochemical relapse in 125I prostate brachytherapy
|
Spadinger, Ingrid |
|
2009 |
8 |
2 |
p. 126 |
article |
149 |
RACS, MACS and LCDS: How to work with them and understand how they affect your practice
|
DiGiaimo, Ron |
|
2009 |
8 |
2 |
p. 156-157 |
article |
150 |
Radioactive seed strand migration after prostate brachytherapy
|
Tuanquin, Leonard C. |
|
2009 |
8 |
2 |
p. 162 |
article |
151 |
Randomized trial comparing intra-operative flexible, regid and no cystoscopy after prostate brachytherapy
|
Sylvester, John E. |
|
2009 |
8 |
2 |
p. 168-169 |
article |
152 |
Rebuttal to Drs. Taghian and Bourgier
|
Wazer, David E. |
|
2009 |
8 |
2 |
p. 190 |
article |
153 |
Rebuttal to Dr. Wazer
|
Taghian, Alphonse G. |
|
2009 |
8 |
2 |
p. 189 |
article |
154 |
Rectal injury doses from permanent prostate brachytherapy
|
Bice, William S. |
|
2009 |
8 |
2 |
p. 124-125 |
article |
155 |
Results of preoperative endocavitary brachytherapy in Stage IB cervical carcinoma
|
Coza, Ovidiu |
|
2009 |
8 |
2 |
p. 144 |
article |
156 |
Risk factors for axillary failure in patients with early stage breast cancer managed with accelerated partial breast irradiation using the MammoSite® breast brachytherapy catheter
|
Aburabia, Majd A. |
|
2009 |
8 |
2 |
p. 107 |
article |
157 |
Robotically-assisted minimally invasive brachytherapy: A series of porcine trials
|
Godfrey, Loren |
|
2009 |
8 |
2 |
p. 157 |
article |
158 |
Salvage high-dose-rate brachytherapy for locally recurrent prostate cancer following primary external beam radiation therapy: Early toxicity results of a prospective study
|
Kollmeier, Marisa A. |
|
2009 |
8 |
2 |
p. 119 |
article |
159 |
SAVI breast brachytherapy device allows expansion of women eligible for accelerated partial breast irradiation to whose with small breasts and narrow skin bridges
|
Scanderbeg, Daniel J. |
|
2009 |
8 |
2 |
p. 124 |
article |
160 |
Seed immobilization technique using laser coagulation for brachytherapy procedure
|
Yan, Kaiguo |
|
2009 |
8 |
2 |
p. 163 |
article |
161 |
Seroma is an expected consequence and not a complication of MammoSite® brachytherapy
|
Patel, Priti S. |
|
2009 |
8 |
2 |
p. 108 |
article |
162 |
Sexual outcomes unaffected by penile bulb dose in prostate brachytherapy
|
Whaley, Jonathan T. |
|
2009 |
8 |
2 |
p. 173 |
article |
163 |
Shrinking the prostate with hormones: Effect on bichemical survival with prostate brachytherapy
|
Thompson Jr., William R. |
|
2009 |
8 |
2 |
p. 177 |
article |
164 |
Skin and chest wall dose with multi-catheter and MammoSite breast brachytherapy: Implications for late toxicity
|
Cuttino, Laurie W. |
|
2009 |
8 |
2 |
p. 223-226 |
article |
165 |
Sleeved seeds decrease gastrointestinal and genitourinary toxicity profiles in real-time intraoperatively planned permanent 125I implants
|
Sharma, Navesh K. |
|
2009 |
8 |
2 |
p. 179-180 |
article |
166 |
Sleeved seeds decrease post-implant hotspots in real-time intraoperatively planned permanent 125I prostate implants
|
Cohen, Randi J. |
|
2009 |
8 |
2 |
p. 179 |
article |
167 |
Spatial distribution and DVH parameters correlation of additional rectal/sigmoid mucosal points, in high-dose-rate intracavitary brachytherapy for carcinoma of the cervix – A dosimetric study
|
Tiwana, Manpreet Singh |
|
2009 |
8 |
2 |
p. 128 |
article |
168 |
Systematic comparison of two methods of bladder contouring in cervix cancer brachytherapy: “Direct” vs. “indirect”
|
Shenfield, Carey B. |
|
2009 |
8 |
2 |
p. 141-142 |
article |
169 |
Table of Contents
|
|
|
2009 |
8 |
2 |
p. A4-A5 |
article |
170 |
Technique for quantifying balloon shape and results of a consistency evaluation
|
Axelrod, Steve |
|
2009 |
8 |
2 |
p. 152-153 |
article |
171 |
Ten-year results in 1577 intermediate/high risk prostate cancer patients treated with external beam radiation therapy and hypofractionated high-dose-rate brachytherapy boost
|
Martinez, Alvaro A. |
|
2009 |
8 |
2 |
p. 109 |
article |
172 |
TG-43U1-based dosimetric characterization of model 67-6520 137Cs brachytherapy source
|
Meigooni, Ali S. |
|
2009 |
8 |
2 |
p. 131 |
article |
173 |
The design and dosimety of a four-channel cylinder for treatment of endometrial cancer with high-dose-rate brachytherapy using the varisource afterloader
|
Hunter, Robert J. |
|
2009 |
8 |
2 |
p. 154-155 |
article |
174 |
The effect of obesity on rectal dosimetry after permanent prostate brachytherapy
|
Patil, Nikhilesh |
|
2009 |
8 |
2 |
p. 218-222 |
article |
175 |
The impact of perineural invasion on biochemical outcome following permanent prostate 125I brachytherapy
|
Gomez-Iturriaga, Alfonso |
|
2009 |
8 |
2 |
p. 174-175 |
article |
176 |
The importance of internal, endoscopically placed fiducials and three dimensional treatment planning in esophageal brachytherapy
|
Koyfman, Shlomo A. |
|
2009 |
8 |
2 |
p. 158 |
article |
177 |
The miniSAVI multicatheter accelerated partial breast irradiation applicator and its use in patients with small lumpectomy cavities and/or inadequate skin distance: Early clinical experience
|
Morcovescu, Serban |
|
2009 |
8 |
2 |
p. 138 |
article |
178 |
The necessity of systematic verification of applicator position in brachytherapy treatment of the vaginal cuff
|
Rodriguez, Silvia |
|
2009 |
8 |
2 |
p. 144-145 |
article |
179 |
The role of androgen deprivation therapy in high-risk prostate cancer with Gleason score 8-10 and prostate-specific antigen ≤15 treated with permanent interstitial brachytherapy
|
Fang, L. Christine |
|
2009 |
8 |
2 |
p. 165 |
article |
180 |
The role of dose escalation with intracavitary brachytherapy in the treatment of localized central nervous system malignancies: Long-term followup of outcomes and toxicities of a prospective study
|
Wernicke, A. Gabriella |
|
2009 |
8 |
2 |
p. 132-133 |
article |
181 |
Time course of prostatic edema post permanent seed implant determined by magnetic resonance imaging
|
Sloboda, Ron |
|
2009 |
8 |
2 |
p. 126 |
article |
182 |
Transperineal injection of hyaluronic acid in the anterior perirectal fat to decrease rectal toxicity from radiation delivered with low-dose-rate brachytherapy for prostate cancer patients
|
Prada, Pedro J. |
|
2009 |
8 |
2 |
p. 210-217 |
article |
183 |
Treatment of locally advanced vaginal cancer with radio-chemotherapy and MRI-guided brachytherapy: Clinical feasibility and first results
|
Rottenfusser, Andrea |
|
2009 |
8 |
2 |
p. 112-113 |
article |
184 |
Treatment parameters associated with acute and late toxicity in patients receiving accelerated partial breast irradiation using the MammoSite® brachytherapy device
|
Kaufman, Isaac |
|
2009 |
8 |
2 |
p. 138-139 |
article |
185 |
Treatment planning considerations for electronic brachytherapy vaginal cylinder applicators
|
Hiatt, Jessica R. |
|
2009 |
8 |
2 |
p. 153-154 |
article |
186 |
Ultrasound elastography – an image guidance tool for prostate brachytherapy
|
Salcudean, Septimiu E. |
|
2009 |
8 |
2 |
p. 125-126 |
article |
187 |
Unexpected toxicity in a patient treated with 3D conformal accelerated partial breast radiotherapy
|
Gupta, Sonia |
|
2009 |
8 |
2 |
p. 207-209 |
article |
188 |
Update of the 131Cs monotherapy trial: Comparison of early urethral symptoms between cesium and iodine
|
Prestidge, Bradley R. |
|
2009 |
8 |
2 |
p. 161-162 |
article |
189 |
Use of optically stimulated luminescence dosimeters for in vivo dosimetry in high-dose-rate gynecological patients
|
Sharma, Renu |
|
2009 |
8 |
2 |
p. 155 |
article |
190 |
Variability in Point A dosimetry for tandem and ring applications
|
Wilkinson, Douglas A. |
|
2009 |
8 |
2 |
p. 155 |
article |
191 |
Variance in bladder and rectal doses in the course of fractionated vaginal cylinder high-dose-rate brachytherapy
|
Yaparpalvi, Ravindra |
|
2009 |
8 |
2 |
p. 145 |
article |
192 |
Variations in Monte Carlo simulations of air kerma strength and impact on delivered dose
|
Melhus, Christopher S. |
|
2009 |
8 |
2 |
p. 146-147 |
article |
193 |
Verification of balloon rotation for the Contura™ multilumen device for accelerated partial breast irradiation
|
Ouhib, Zoubir |
|
2009 |
8 |
2 |
p. 123 |
article |
194 |
Verification of low-dose-rate brachytherapy theraputic gain or excess complications from hyperradiosensitivity from low-dose-rate “inverse” dose rate effect
|
Lucas, Arthur C. |
|
2009 |
8 |
2 |
p. 157 |
article |
195 |
What is the optimal insertion angle of MammoSite® balloon in partial breast brachytherapy? A dosimetric point of view
|
Gao, Mingcheng |
|
2009 |
8 |
2 |
p. 137 |
article |
196 |
Whole pelvic radiotherapy in combination with transperineal interstitial brachytherapy: Does coverage of the pelvic lymph nodes improve treatment outcome in high-risk prostate cancer?
|
Bittner, Nathan |
|
2009 |
8 |
2 |
p. 110-111 |
article |
197 |
X-ray target composed of miniaturized structures for brachytherapy x-ray tubes
|
Ihsan, Aamir |
|
2009 |
8 |
2 |
p. 151 |
article |
198 |
10-year experience with 125I prostate brachytherapy at Princess Margaret Hospital
|
Crook, Juanita M. |
|
2009 |
8 |
2 |
p. 163 |
article |
199 |
10-year results of interstitial needle-catheter brachytherapy for accelerated partial breast irradiation: Excellent control rates with minimal toxicities
|
Chen, Peter Y. |
|
2009 |
8 |
2 |
p. 105 |
article |